Conference: SCDM US Annual Conference 2026
Date: September 14 - 17, 2026
Location: Raleigh, NC
Booth: 443
Hear key learning objectives and insights from our experts
Author: Ragini Hari
Regulatory approval remains the ultimate goal for the majority of clinical trials, yet what appears complete at first glance may not fully withstand regulatory scrutiny. While implementation of CDISC standards has increased yearly and standards compliance has significantly improved, approval cannot be guaranteed based solely on standards and regulatory conformance.
Validation plays a critical role in confirming datasets meet predefined structural requirements. However, while rule-based checks ensure compliance, they may not reveal flaws in other aspects critical for regulatory review.
This presentation will examine common challenges encountered on the path to regulatory approval and consider how these challenges extend beyond traditional validation. The benefits of standardization in enabling consistency and interoperability will be highlighted, alongside areas where additional focus is needed. Finally, potential solutions will be explored, moving us beyond the illusion that CDISC and regulatory conformance alone ensure approval and closer to revealing workflows to truly vet our submissions.
Booth demos
Presenter: Amy Garrett
Presenter: Julie Ann Hood
Presenter: Amy Garrett
Watch this short video and see how to achieve submission ready conformance with Pinnacle 21
Meet us there
Pre-book a free, no-obligation meeting with our technical experts at the show. Simply provide a few details and we’ll come armed with the right resources to best advise you.
You May Also Like
From first-in-human trials to global regulatory approvals and post-launch, Certara solutions can help you move your science forward faster, with confidence.
